{
    "code": "51058628",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058628",
    "time": "2020-02-26 06:16:48",
    "許可證字號": "衛部藥製字第058628號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/03\/04",
    "發證日期": "104\/03\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105862807",
    "中文品名": "&quot;台裕&quot;康思寧持續性藥效錠200毫克",
    "英文品名": "Q-pine XR Extended-Release Tablets 200mg &quot;Tai Yu&quot;",
    "適應症": "治療思覺失調症、雙極性疾患之鬱症發作、躁症發作及混合性發作。對於抗鬱劑單一藥物治療效果不佳的重鬱症(MDD)病人，可作為重鬱症發作的附加治療。開始治療之前，臨床醫師應該考慮Quetiapine XR的安全性。",
    "劑型": "164持續性藥效膜衣錠",
    "包裝": "2-1000錠PTP 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
        "申請商名稱": "6133030016  台裕化學製藥廠股份有限公司",
        "申請商地址": "新竹縣竹東鎮員山路11巷13弄1號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037620",
            "成分名稱": "QUETIAPINE FUMARATE",
            "含量描述": "(eq. to Quetiapine 200mg)",
            "含量": "230.2700000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "19.19*7.1",
        "特殊劑型": "",
        "顏色": "黃色至類黃色",
        "特殊氣味": "無",
        "刻痕": "無",
        "形狀": "橢圓形",
        "標記一": "無",
        "標記二": "無"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[外觀]058628康思寧持續性藥效錠(200毫克)-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058628&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "058628康思寧持續性藥效錠 200mg-仿單B-105-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058628&Seq=004&Type=9"
        },
        {
            "title": "058628康思寧持續性藥效錠200mg-彩盒-105-08-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058628&Seq=007&Type=8"
        }
    ]
}